abstract |
A TREATMENT FOR ABERRANT CALCIUM RELATED DEPOSITS IN ANIMAL TISSUES, INCLUDING ARTERIOSCLEROSIS, COMPRISES THE ORAL ADMINISTRATION OF EDTA CONCURRENTLY WITH MONITOR ING FOR DEPLETION OF METABOLIC TRACE METALS, AND REPLACEMENT OF THE TRACE METALS AS INDICATED. |